focus -WSS

focus

author：fashion 2025-10-06 09:12:42 - browse：69378

a liver made up by geometric shapes – biotech coverage from STAT — Adobe

Intercept Pharmaceuticals, a firm whose treatment for a prevalent liver disease once made it the hottest stock in biotech, said Tuesday it would sell the company for less than $1 billion.

Alfasigma, an Italian pharmaceutical firm, will pay $19 a share for Intercept, in a roughly $800 million cash deal that represents an 80% premium to the company’s recent trading price. Intercept expects the deal to close by the end of the year.

The transaction comes three months after the Food and Drug Administration rejected Intercept’s treatment for NASH, an increasingly common fatty liver disease perceived as a potential gold mine by drug companies. Intercept’s medicine, called obeticholic acid, would have been the first approved treatment for NASH, but serious concerns about the risk of drug-related liver damage and uncertainty over whether its modest effects would improve patients’ lives made it unapprovable in the eyes of the FDA.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： Ukrainian soldiers say they owe lives to US

WSS

Thousands protest in Iraq for a second day over burning of Quran in Sweden

IVF doctors demand details after CooperSurgical lawsuit

Stem cell biologist probes earliest stages of human development

Pregnant women don't need prenatal multivitamins, study concludes

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Lilly’s obesity pill cuts 15% of weight at highest dose in mid

focus

focus

Wikipedia

After affirmative action ruling, medical educators look to 'holistic review'

A new approach to psychiatric drug development

State Dept. review finds Biden bears some blame for Afghanistan failures

Thousands protest in Iraq for a second day over burning of Quran in Sweden

Drug repurposing or repositioning? The language matters

Synthetic human embryos? Researchers say term is overblown

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Families look for replacement for GSK asthma drug Flovent

Alkermes shareholders re

Change Healthcare: What is it, why does its cyberattack matter?

hotspot

The strange history of BMI, the body mass index

ADA: All diabetes patients should be screened for liver condition

Belarusian journalist sentenced to 4 years in prison as crackdown continues

The public health thinking behind the CDC’s new Covid guidance

Ozempic has benefits for kidney disease as well as diabetes

State of the Union pitch: Bigger Medicare drug price negotiations

focus

hotspot

entertainment

explore